Literature DB >> 35406451

Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Alicia Cristina Peña-Romero1, Esteban Orenes-Piñero1.   

Abstract

Our body is constantly exposed to pathogens or external threats, but with the immune response that our body can develop, we can fight off and defeat possible attacks or infections. Nevertheless, sometimes this threat comes from an internal factor. Situations such as the existence of a tumour also cause our immune system (IS) to be put on alert. Indeed, the link between immunology and cancer is evident these days, with IS being used as one of the important targets for treating cancer. Our IS is able to eliminate those abnormal or damaged cells found in our body, preventing the uncontrolled proliferation of tumour cells that can lead to cancer. However, in several cases, tumour cells can escape from the IS. It has been observed that immune cells, the extracellular matrix, blood vessels, fat cells and various molecules could support tumour growth and development. Thus, the developing tumour receives structural support, irrigation and energy, among other resources, making its survival and progression possible. All these components that accompany and help the tumour to survive and to grow are called the tumour microenvironment (TME). Given the importance of its presence in the tumour development process, this review will focus on one of the components of the TME: immune cells. Immune cells can support anti-tumour immune response protecting us against tumour cells; nevertheless, they can also behave as pro-tumoural cells, thus promoting tumour progression and survival. In this review, the anti-tumour and pro-tumour immunity of several immune cells will be discussed. In addition, the TME influence on this dual effect will be also analysed.

Entities:  

Keywords:  cancer; immune cells; immune evasion; immune system; immunosurveillance; tumour microenvironment

Year:  2022        PMID: 35406451      PMCID: PMC8996887          DOI: 10.3390/cancers14071681

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  502 in total

Review 1.  Antibody-independent functions of B cells: a focus on cytokines.

Authors:  Ping Shen; Simon Fillatreau
Journal:  Nat Rev Immunol       Date:  2015-06-12       Impact factor: 53.106

Review 2.  Eosinophils: The unsung heroes in cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Valeria Lucarini; Giancarlo Marone; Fabrizio Mattei; Gianni Marone; Giovanna Schiavoni
Journal:  Oncoimmunology       Date:  2017-11-13       Impact factor: 8.110

Review 3.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

4.  Mast cell targeting hampers prostate adenocarcinoma development but promotes the occurrence of highly malignant neuroendocrine cancers.

Authors:  Paola Pittoni; Claudio Tripodo; Silvia Piconese; Giorgio Mauri; Mariella Parenza; Alice Rigoni; Sabina Sangaletti; Mario P Colombo
Journal:  Cancer Res       Date:  2011-09-06       Impact factor: 12.701

5.  Gastric cancer cells induce human CD4+Foxp3+ regulatory T cells through the production of TGF-β1.

Authors:  Xiang-Liang Yuan; Lei Chen; Tong-Tong Zhang; Yan-Hui Ma; Yun-Lan Zhou; Yan Zhao; Wei-Wei Wang; Ping Dong; Liang Yu; Yan-Yun Zhang; Li-Song Shen
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

6.  Fatty acid transport protein 2 reprograms neutrophils in cancer.

Authors:  Filippo Veglia; Vladimir A Tyurin; Maria Blasi; Alessandra De Leo; Andrew V Kossenkov; Laxminarasimha Donthireddy; Tsun Ki Jerrick To; Zach Schug; Subhasree Basu; Fang Wang; Emanuela Ricciotti; Concetta DiRusso; Maureen E Murphy; Robert H Vonderheide; Paul M Lieberman; Charles Mulligan; Brian Nam; Neil Hockstein; Gregory Masters; Michael Guarino; Cindy Lin; Yulia Nefedova; Paul Black; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

7.  CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer.

Authors:  Letizia Porcelli; Rosa Maria Iacobazzi; Roberta Di Fonte; Simona Serratì; Angelica Intini; Antonio Giovanni Solimando; Oronzo Brunetti; Angela Calabrese; Francesco Leonetti; Amalia Azzariti; Nicola Silvestris
Journal:  Cancers (Basel)       Date:  2019-03-07       Impact factor: 6.639

Review 8.  Revisiting the role of CD4+ T cells in cancer immunotherapy-new insights into old paradigms.

Authors:  Rong En Tay; Emma K Richardson; Han Chong Toh
Journal:  Cancer Gene Ther       Date:  2020-05-27       Impact factor: 5.987

9.  A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy.

Authors:  Xuexiang Du; Fei Tang; Mingyue Liu; Juanjuan Su; Yan Zhang; Wei Wu; Martin Devenport; Christopher A Lazarski; Peng Zhang; Xu Wang; Peiying Ye; Changyu Wang; Eugene Hwang; Tinghui Zhu; Ting Xu; Pan Zheng; Yang Liu
Journal:  Cell Res       Date:  2018-02-22       Impact factor: 25.617

View more
  4 in total

Review 1.  The Role of the NLRP3 Inflammasome in HCC Carcinogenesis and Treatment: Harnessing Innate Immunity.

Authors:  Stavros P Papadakos; Nikolaos Dedes; Elias Kouroumalis; Stamatios Theocharis
Journal:  Cancers (Basel)       Date:  2022-06-27       Impact factor: 6.575

2.  Establishment of Nomogram Model for Minimally Invasive Treatment of Small Hepatocellular Carcinoma Based on CD8+T Cell Counts.

Authors:  Qing Pu; Lihua Yu; Xinhui Wang; Huiwen Yan; Yuqing Xie; Juan Du; Zhiyun Yang
Journal:  Onco Targets Ther       Date:  2022-08-31       Impact factor: 4.345

3.  A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma.

Authors:  Jianqing Zheng; Xiaohui Chen; Bifen Huang; Jiancheng Li
Journal:  Front Genet       Date:  2022-09-06       Impact factor: 4.772

Review 4.  Mechanosensitive Ion Channel PIEZO1 Signaling in the Hall-Marks of Cancer: Structure and Functions.

Authors:  Fuqiang Zhao; Lei Zhang; Mankun Wei; Wei Duan; Shourong Wu; Vivi Kasim
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.